Venetoclax First Cycle Treatment in a Case of Severe AML FAB M2 and COVID-19 Pneumoniae: A Rare Clinical Scenario

Gaba, Radu (2021) Venetoclax First Cycle Treatment in a Case of Severe AML FAB M2 and COVID-19 Pneumoniae: A Rare Clinical Scenario. Asian Hematology Research Journal, 4 (1). pp. 12-18.

[thumbnail of 30146-Article Text-56536-1-10-20210201.pdf] Text
30146-Article Text-56536-1-10-20210201.pdf - Published Version

Download (214kB)

Abstract

Here we describe a rare case of a venetoclax first cycle treatment in a case of a newly diagnosed COVID-19 pneumoniae.

Item Type: Article
Subjects: Lib Research Guardians > Medical Science
Depositing User: Unnamed user with email support@lib.researchguardians.com
Date Deposited: 11 Feb 2023 09:14
Last Modified: 01 Jan 2024 12:57
URI: http://journal.edit4journal.com/id/eprint/112

Actions (login required)

View Item
View Item